A critical advance in cancer research is emerging with the use of mini-antibodies to reactivate mutated p53. This essential tumor protector protein is frequently inactivated in various types of tumors, leading https://worldsocialindex.com/story7056071/mini-antibodies-reactivate-p53-new-new-approach-for-malignant-management